PRTA Q2 2020 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$195,000+16.8% YoY

Gross Profit

-$17M-8756.9% margin

Operating Income

-$27M-13708.7% margin

Net Income

-$26M-13477.9% margin

EPS (Diluted)

$-0.66

QoQ Revenue Growth

+38.3%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$379M

Total Liabilities

$144M

Stockholders' Equity

$234M

Cash & Equivalents

$334M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$195,000	$167,000	+16.8%
Gross Profit	-$17M	-$9M	-81.4%
Operating Income	-$27M	-$18M	-44.5%
Net Income	-$26M	-$16M	-66.2%

Revenue Segments

Collaboration

$145,00074%

License

$50,00026%